| O.1 | Approval of the financial statements | For |
| O.2 | Discharge the Board | Oppose |
| O.3 | Approval of the consolidated financial statements | For |
| O.4 | Allocation of income | For |
| O.5 | Approve Transaction with Merieux Participations Re: Acquisition of Shares of Advencis | For |
| O. 6 | Approve regulated sponsorship agreement entered into between the company and Fondation Merieux, and presented in the special report of the Statutory Auditors | For |
| O.7 | Approve sponsorship agreement entered into between the company and the Fondation Christophe and Rodolphe Merieux, and presented in the special report of the Statutory Auditors | For |
| O.8 | Approve regulated service agreement entered into between the company and the Fondation Merieux, and presented in the special report of the Statutory Auditors | For |
| O.9 | Approve regulated service agreement entered into between the company and the Institut Merieux, and presented in the special report of the Statutory Auditors | Oppose |
| O.10 | Approve regulated agreement entered into between the company and Institut Merieux, Merieux Nutrisciences Corporation, Transgene, Abl And Merieux Developpement concerning the distribution of costs of employment contracts termination, and presented in the Special Report of the Statutory Auditors | For |
| O.11 | Advisory review on the compensation owed or paid to Jean-Luc Belingard, Chairman and Chief Executive Officer | Oppose |
| O.12 | Advisory review on the compensation owed or paid to the Alexandre Mérieux, Chief Operating Officer | Oppose |
| O.13 | Authorise Share Repurchase | Oppose |
| E.14 | Reduce Share Capital by cancellation of treasury shares | For |
| E.15 | Issue shares with pre-emption rights | Oppose |
| E.16 | Approve authority to increase authorised share capital and issue shares without pre-emptive right | Oppose |
| E.17 | Approve authority to issue shares without pre-emptive rights via private placement | Oppose |
| E.18 | Authorise Board to deviate from pricing conditions | Oppose |
| E.19 | Authorise Board to increase the number of shares to be issued in case of capital increase | Oppose |
| E.20 | Issue shares without pre-emptive rights in consideration for in-kind contributions | Oppose |
| E.21 | Authorise the Board to increase share capital by incorporation of reserves, profits, premiums or other amounts | For |
| E.22 | Authorise Board to issue shares following the issuance by subsidiaries and/or the parent company | Oppose |
| E.23 | Authorise Board to issue shares reserved for employees participating in the company savings plan | Oppose |
| E.24 | Cancellation of pre-emptive rights for the benefits of employees participating in the company savings plan | For |
| E.25 | Overall limitation on issuance authorisations | For |
| E.26 | Authorise Board to allocate free shares existing or to be issued without pre-emptive rights | Oppose |
| E.27 | Delegate authority to the Board in case of allotment of new shares to be issued pursuant to the previous resolution | For |
| O.28 | Powers to any bearer of an orginal of the minutes of this meeting to carry out all legal formalities | For |
